Amelioration of the deleterious effects of platelets activated during cardiopulmonary bypass
- 1 February 1985
- journal article
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 89 (2) , 190-195
- https://doi.org/10.1016/s0022-5223(19)38813-0
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Kinetics and imaging of indium-11-labeled autologous platelets in experimental myocardial infarction.Circulation, 1983
- A Platelet-Inhibitor-Drug Trial in Coronary-Artery Bypass OperationsNew England Journal of Medicine, 1982
- A Double Blind Study of Prostacyclin in Cardiopulmonary Bypass SurgeryBritish Journal of Haematology, 1981
- Thromboxane and prostacyclin release from ischaemic myocardium in relation to arrhythmiasNature, 1981
- PROSTACYCLIN ADMINISTRATION DURING CARDIOPULMONARY BYPASS IN MANThe Lancet, 1981
- Synthesis of Prostacyclin from Platelet-derived Endoperoxides by Cultured Human Endothelial CellsJournal of Clinical Investigation, 1980
- Platelet Loss during Experimental Cardiopulmonary Bypass and Its Prevention with ProstacyclinThe Annals of Thoracic Surgery, 1980
- Platelet Dysfunction Associated with Cardiopulmonary BypassThe Annals of Thoracic Surgery, 1978
- Experimental ischemic heart disease induced by thromboxane A2 in rabbits.Japanese Circulation Journal, 1978
- Heart attack induced experimentally with thromboxane A2.Proceedings of the Japan Academy, Series B, 1977